Medical expert of the article
New publications
Goji berries for diabetes: can you eat them and how much?
Last updated: 27.10.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Goji berries (Lycium barbarum) are widely promoted as a "natural remedy" for improving metabolism and glucose control, but the evidence is often weaker than the claims. For people with diabetes, the key is to understand whether there is clinical benefit and how the potential effects compare to safety and existing treatments. [1]
Modern reviews point to the rich phytochemical composition of goji berries and potential metabolic mechanisms, but most of the data is derived from animal and laboratory experiments. This is important as a scientific basis, but not sufficient to recommend the berries for the treatment of diabetes. [2]
Key diabetes clinical guidelines emphasize that dietary supplements and herbs, in general, have not demonstrated convincing and reproducible glucose-lowering effects in humans and therefore are not considered standard therapy. The mainstays of treatment remain diet, physical activity, medications, and risk factor management. [3]
Goji berries have safety concerns, however. Potential interactions with warfarin and theoretical interactions with drugs metabolized by certain enzyme systems have been described. This is crucial for people with polypharmacy and other underlying conditions. [4]
Brief conclusion on the evidence
To date, there are very few or no high-quality randomized clinical trials that conclusively demonstrate glucose reduction or improvement in glycated hemoglobin in humans with goji berries. The available data are primarily preclinical. Conclusion: Goji berries should not be used as a treatment for diabetes. [5]
Lycium barbarum polysaccharides are being actively studied as candidates for metabolic effects in animal models of insulin resistance and diabetes. Effects on microbiota, inflammation, and oxidative stress have been demonstrated, but translating these findings to humans requires clinical confirmation. [6]
The American Diabetes Association's 2025 guidelines reiterate its position: supplements have not been proven effective for routine glucose control, and recommendations focus on interventions with proven benefit. This includes goji berries. [7]
The practical point for patients is to consider goji berries as a food product within a varied diet, not as a medicine. Any experiments with supplements should only be conducted in conjunction with background therapy, including glucose monitoring, as agreed upon by a physician. [8]
Table 1. Strength of evidence for goji berries in diabetes
| Question | What is shown | Level of evidence |
|---|---|---|
| Lowering glucose levels in humans | there is no convincing clinical data | very low |
| Effect on insulin resistance in animals | there are signals in several works | short |
| Improving oxidative stress markers in preclinical models | observed | short |
| Safety of long-term use in humans | systematic data are limited | very low |
Collection of reviews and experimental works. [9]
Composition and possible mechanisms
Goji berries contain Lycium barbarum polysaccharides, carotenoids, flavonoids, and other phenolic compounds. In laboratory studies, these substances exhibit antioxidant and anti-inflammatory properties, as well as inhibitory activity against certain digestive enzymes. However, such data do not equate to proven clinical benefit in humans. [10]
Lycium barbarum polysaccharides are discussed as potential modulators of the microbiota and inflammatory pathways associated with insulin resistance. In preclinical models, they sometimes improved insulin sensitivity and reduced inflammatory markers. Without human studies, this remains a hypothesis. [11]
Recent reviews have concluded that Lycium barbarum may affect carbohydrate metabolism enzymes and pancreatic beta-cell signaling in animal models, but clinical reproducibility has not been demonstrated. Randomized trials with relevant endpoints in patients are needed. [12]
Even if some of these mechanisms are confirmed in humans, the effect is likely to be moderate and supportive. Therefore, goji berries should be considered part of a varied diet rather than a replacement for drug therapy. [13]
Table 2. Main groups of substances and expected effects
| Group of compounds | Examples | Intended action |
|---|---|---|
| Polysaccharides | LBP complex | antioxidant, anti-inflammatory, effects on microbiota |
| Carotenoids | zeaxanthin | antioxidant, vision support as a general benefit |
| Flavonoids and phenolic acids | quercetin, chlorogenic acid | antioxidant, theoretical effect on carbohydrate metabolism enzymes |
| Other components | amino acids, minerals | nutritional value without proven glycemic effect |
Summarized from reviews of phytochemistry and applied research. [14]
What the research says
Systematic reviews and case studies show that most positive results on glycemia are from animal experiments or small pilot studies that cannot be considered definitive evidence. This is insufficient for clinical recommendations. [15]
Animal studies demonstrate that diets enriched with goji berries or their polysaccharides can improve insulin resistance and inflammatory markers. However, the doses and forms used in these studies differ from typical dietary intake and are not directly applicable to humans. [16]
There are no large randomized trials in humans with glycated hemoglobin as the primary endpoint. This is a key gap that precludes the proven clinical efficacy of goji berries in diabetes. [17]
With this in mind, clinicians are guided by diabetes management standards and view goji berries as part of the diet, not as a therapeutic tool. Patients are advised to discuss any supplements with their physician and not to change their underlying treatment on their own. [18]
Table 3. Summary of glycemic data
| Data type | Model | Form | Glycemic summary |
|---|---|---|---|
| Animal experiments | mice, rats | berries or polysaccharides | moderate signs of improvement |
| Small pilot data in humans | limited | juice, extract | not enough to draw conclusions |
| Randomized trials in humans | are absent | not applicable | there is no evidence |
Collection of publications and reviews. [19]
Safety and contraindications
When consumed in moderation, goji berries are generally considered tolerable for healthy adults; however, allergic reactions and dyspepsia are possible in sensitive individuals. There is no standardized safety information for long-term use at medicinal doses in patients with diabetes. [20]
Drug interactions are of greatest practical importance. Clinical cases have been described of increased anticoagulant effects of warfarin when drinking tea or drinks containing goji berries, leading to an increase in the international normalized ratio and a risk of bleeding. This interaction is considered probable. [21]
There is laboratory evidence of the potential influence of berry components on enzymatic systems involved in drug metabolism, which could theoretically alter the concentrations of some drugs. The clinical significance beyond warfarin has not been adequately studied, so caution is advised. [22]
Particular caution should be exercised by pregnant and lactating women, the elderly, patients with chronic liver or kidney disease, and those taking multiple medications simultaneously. Any deterioration in health after starting treatment should prompt discontinuation of the product and consultation with a specialist. [23]
Table 4. Potential risks and attention groups
| Risk | Who cares? | Comments |
|---|---|---|
| Bleeding in the context of warfarin | everyone on anticoagulant therapy | Clinical cases of increased international normalized ratio are described |
| Drug interactions through enzyme systems | patients on multiple therapy | clinical significance has been studied to a limited extent |
| Allergic reactions | people with allergies to plants and fruits | skin manifestations, itching, dyspepsia |
| Lack of long-term safety data | all patients with diabetes | avoid high doses without medical supervision |
Summarized by cases and reviews. [24]
Drug interactions
A potential interaction with warfarin is supported by several clinical observations and pharmacological data. Patients on anticoagulants should avoid Lycium barbarum-containing drinks and supplements or report the risk to their physician and monitor their international normalized ratio (INR) more frequently. [25]
Theoretically, goji berries may influence the concentrations of drugs metabolized through isoenzymes, including the CYP2C9 system. The clinical implications of such interactions beyond warfarin remain unclear, so it is prudent to apply the precautionary principle.[26]
Goji berries may also enhance the effects of hypoglycemic medications, increasing the risk of hypoglycemia, although clinical evidence is limited. Patients who do introduce the product into their diet should check their glucose levels more frequently and discuss any changes with their doctor. [27]
If you start or stop consuming goji berries or goji drinks, be sure to tell your doctor, especially if you have recently changed your insulin or oral medication doses. This will help accurately interpret fluctuations in blood sugar and symptoms. [28]
Table 5. Risk areas for interactions to discuss with your doctor
| Zone | Examples of medications | What to look at |
|---|---|---|
| Anticoagulation | warfarin | international normalized ratio, signs of bleeding |
| Glycemia | insulin, sulfonylurea derivatives, meglitinides | Frequent self-monitoring for symptoms of hypoglycemia |
| Drug metabolism | drugs metabolized through CYP2C9 | side effects and effectiveness |
Summary of cases and positions of clinical organizations. [29]
Practical recommendations for the patient
Think of goji berries as a food, not a medicine. If you enjoy them, enjoy them in moderation as part of an overall healthy diet, along with vegetables, legumes, whole grains, and sources of healthy fats. This is consistent with diabetes nutrition principles. [30]
Do not start taking concentrated extracts or drinks containing high doses of berries without consulting your doctor, especially if you are taking warfarin or other medications. Be aware that there are products on the market with unpredictable compositions and without strict standardization. [31]
If you do add goji berries to your diet, start with small amounts, measure your glucose levels more frequently during the first few weeks, and monitor your health. If you experience any unusual symptoms or unstable blood sugar, discontinue use and consult a healthcare professional. [32]
Rely on diabetes management standards. Evidence-based strategies provide the primary contribution to glycemic control: nutrition, physical activity, prescribed therapy, blood pressure and lipid management, smoking cessation, and regular monitoring. Goji berries do not replace these foundations. [33]
Result
The evidence base for goji berries in diabetes is limited to preclinical and small-scale data, which precludes their recommendation as a treatment. Given potential drug interactions and the lack of clinical evidence of a glycemic effect, goji berries should only be used as part of a diet and after consultation with a physician. [34]

